GenoMe Diagnostics

Belfast, United Kingdom

GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests.

$1.7M raised

Mar 2023

Seed

Health Diagnostics Medical Product Research

Top Investors

Innovate UK Deepbridge Capital QUBIS Co-FundNI

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about GenoMe Diagnostics

How much funding has GenoMe Diagnostics raised?

GenoMe Diagnostics has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2023.

Who are GenoMe Diagnostics's investors?

GenoMe Diagnostics's investors include Innovate UK, Deepbridge Capital, QUBIS, Co-FundNI.

Where is GenoMe Diagnostics headquartered?

GenoMe Diagnostics is headquartered in Belfast, United Kingdom.

What does GenoMe Diagnostics do?

GenoMe Diagnostics develops OvaME product that helps in improvement of status quo of CA125 blood tests.

What stage is GenoMe Diagnostics at?

GenoMe Diagnostics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 3, 2023.

MLA

"GenoMe Diagnostics — Funding & Investors." VCBacked, March 3, 2023, https://www.vcbacked.co/company/genome-diagnostics. Accessed July 1, 2026.

APA

VCBacked. (2023). GenoMe Diagnostics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/genome-diagnostics

Wikipedia (cite web)

{{cite web |title=GenoMe Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/genome-diagnostics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 3, 2023.

Similar Companies in Health Diagnostics

Blue Note Therapeutics